Amphastar Pharma (AMPH) Tops Q1 EPS by 5c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.74, $0.05 better than the analyst estimate of $0.69. Revenue for the quarter came in at $170.5 million versus the consensus estimate of $174.35 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Pacific Booker Minerals Inc. Adopts Advance Notice Policy for Director Elections
• NSA lost access to powerful AI model amid Anthropic dispute - NYT